Acticor Biotech appoints François Guilletas Chief Financial Officer
Paris, France, Octobre 14, 2024 – 08:00am CEST – ACTICOR BIOTECH (FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, today announces the appointment of François Guillet as Chief Financial Officer, replacing Éric Cohen who is leaving to pursue other projects. Gilles AVENARD, Chief Executive Officer and founder of Acticor Biotech, comments: “We are delighted to … Continue reading Acticor Biotech appoints François Guilletas Chief Financial Officer